Longitudinal diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease
Section snippets
Objective
Dementia with Lewy bodies (DLB) is a common form of neurodegenerative dementia in older people, second to Alzheimer's disease (AD). Studies of DLB have found relatively less overall brain atrophy than AD, particularly in the temporal lobes [1]. A number of studies have investigated the structural integrity of the white matter in DLB using MR diffusion tensor imaging (DTI) and have found mixed results, but generally, DLB subjects have DTI changes in parieto-occipital regions, whilst AD changes
Subjects
Seventy-one individuals aged over 60 (36 subjects with probable AD [4] and 35 with probable DLB [5]) were recruited from a community-dwelling population of patients referred to local old age psychiatry, geriatric medicine, or neurology services. Thirty-five control subjects were recruited from relatives and friends of subjects with dementia or volunteered via local advertisements. All subjects underwent clinical and neuropsychological evaluations with diagnostic procedures as previously
Statistics
We used SPSS (version 22, IBM, New York, USA) for analysis of non imaging data. Group comparisons were performed with ANOVA or Chi square. Comparison of mean FA and MD controlling for covariates was done with the general linear model, with fixed factors of group and sex, and covariates of age and deep WMH rating. Correlations were performed with Pearson correlation.
Results
Table 1 shows the subject demographics of the study participants with repeat DTI data. AD and DLB were well matched for overall cognitive impairment, though as expected, AD subjects performed worst on baseline episodic memory. The DLB subjects showed significant progression of motor features as assessed by increased UPDRS (p = 0.045). There were no significant differences between groups in WMH rating score. WMH score was significantly correlated (p < 0.001) with both mean FA and MD in the whole
Conclusions
We found increase of mean diffusivity over 1 year in the AD group to be greater than that in the control group over a wide range of brain areas. The increase in MD in AD was also greater than that in DLB in parietal and temporal regions. However, there was no evidence of longitudinal change in MD or FA in DLB relative to controls. This suggests that the widespread pattern of increased MD and reduced FA in AD that we saw at baseline is part of an ongoing degenerative process, whilst the
Study funding
The study was funded by the Sir Jules Thorn Charitable Trust (grant ref: 05/JTA).
Financial disclosure
John O'Brien has been a consultant for GE Healthcare, Servier, and Bayer Healthcare and has received honoraria for talks from Pfizer, GE Healthcare, Eisai, Shire, Lundbeck, Lilly, and Novartis. All other authors have no conflicts of interest to declare.
Acknowledgements
The study was supported by the NIHR Biomedical Research Unit in Dementia and the Biomedical Research Centre awarded to Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge, and the NIHR Biomedical Research Unit in Dementia and the Biomedical Research Centre awarded to Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. Elijah Mak was in receipt of a Gates Cambridge PhD studentship.
References (20)
- et al.
Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment
Neuroscience
(2014) - et al.
Threshold-free cluster enhancement:Addressing problems of smoothing, threshold dependence and localisation in cluster inference
NeuroImage
(2009) - et al.
Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies
NeuroImage Clin.
(2015) - et al.
Longitudinal cerebral diffusion changes reflect progressive decline of language and cognition
Psychiat Res. Neuroim
(2013) - et al.
Longitudinal white matter changes in Alzheimer's disease: a tractography-based analysis study
Brain Res.
(2013) - et al.
Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging
NeuroImage Clin.
(2013) - et al.
Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease
Magn. Reson Imaging
(2013) - et al.
DTI measures in crossing-fibre areas: Increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease
NeuroImage
(2011) - et al.
CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment
NeuroImage
(2014) - et al.
Neuroimaging characteristics of dementia with Lewy bodies
Alzheimers Res. Ther.
(2014)
Cited by (26)
Biomarkers of Alzheimer's disease: Past, present and future clinical use
2023, Biomarkers in NeuropsychiatryAbnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: A systematic review
2023, Ageing Research ReviewsMicrostructural mapping of dentate gyrus pathology in Alzheimer's disease: A 16.4 Tesla MRI study
2023, NeuroImage: ClinicalFunctional Imaging for Neurodegenerative Diseases
2022, Presse MedicaleCitation Excerpt :DLB also showed FA alterations with a different time span compared to AD [42]. Frontal and temporal white matter tracts have been consistently shown to be damaged in patients with frontotemporal dementia (bvFTD) [42-47]. Diffusion tensor MRI has been found to be helpful in differentiating bvFTD from AD as the site of the damaged fibres differs, with localisation in frontal white matter for bvFTD and mainly in parietal regions in AD.
Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention
2022, Ageing Research ReviewsCitation Excerpt :Results could show disruption of pathways within the limbic system like the fornix and cingulum (Chandra et al., 2019; Bozoki et al., 2012; Zhu et al., 2013). In AD, DTI gives an estimation of the risk of conversion from MCI to overt AD (Chandra et al., 2019; Brueggen et al., 2015) and also aids in distinguishing AD from DLB patients (Zhang et al., 2009; Firbank et al., 2016) with significant statistics (Box 1). However, DTI might not be suitable for clinical use due to frequent motion artifacts as a result of long scanning time (Mori and Zhang, 2006).
Correlation of microglial activation with white matter changes in dementia with Lewy bodies
2020, NeuroImage: Clinical